Clinical trial
Efficacy Study of Low-Dose Hydrocortisone Treatment for Fibromyalgia
NCT00236925 · Ludwig-Maximilians - University of Munich, Other · Completed
Key facts
| NCT number | NCT00236925 |
|---|---|
| Title | Efficacy Study of Low-Dose Hydrocortisone Treatment for Fibromyalgia |
| Official title | A Double-Blind Crossover Within Subject Study on Low-Dose Hydrocortisone for Fibromyalgia |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Collaborators | University of Zurich |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Low dose Hydrocortisone, Placebo |
| Enrollment | 30 |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Oct 12, 2005 |
| Last update posted | Mar 15, 2024 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: